Ladarixin
Ladarixin (DF 2156A free base) is an orally active, non-competitive CXCR1/CXCR2 allosteric inhibitor that suppresses AKT, NF-κB, and angiogenesis, thereby slowing the progression of experimental human melanoma. It may be employed in research concerning COPD, asthma, and melanoma.
Product Specifications
CAS Number
849776-05-2
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.36% (May vary between batches)
Smiles
C[C@@H] (C (=O) NS (C) (=O) =O) c1ccc (OS (=O) (=O) C (F) (F) F) cc1
Molecular Formula
C11H12F3NO6S2
Molecular Weight
375.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR204134L3V 200 µL
Slc25a5 (NM_007451) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details MBS1344372-01 0.02 mg (E-Coli)
Recombinant Human Probable E3 ubiquitin-protein ligase TRIML2 (TRIML2)
Sign In for Pricing
View Details MBS1344372-02 0.02 mg (Yeast)
Recombinant Human Probable E3 ubiquitin-protein ligase TRIML2 (TRIML2)
Sign In for Pricing
View Details MBS1344372-03 0.1 mg (E-Coli)
Recombinant Human Probable E3 ubiquitin-protein ligase TRIML2 (TRIML2)
Sign In for Pricing
View Details MBS1344372-04 0.1 mg (Yeast)
Recombinant Human Probable E3 ubiquitin-protein ligase TRIML2 (TRIML2)
Sign In for Pricing
View Details MBS1344372-05 0.02 mg (Baculovirus)
Recombinant Human Probable E3 ubiquitin-protein ligase TRIML2 (TRIML2)
Sign In for Pricing
View Details